Patents expiring in 2039

US 10357539

Use of peptides that block metadherin-SND1 interaction as treatment for cancer

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10357522

Bacteriophage compositions and methods of selection of components against specific bacteria

United States of America as represented by the Secretary of the Air Force · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10357510

Metal nanoclusters and uses thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10357484

Heterocyclic compound

Takeda Pharmaceutical Company Limited · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10357465

Eutectic formulations of cyclobenzaprine hydrochloride

TONIX PHARMA LIMITED · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10357217

Method for positron emission tomography (PET) imaging analysis for classifying and diagnosing of neurological diseases

The Regents of the University of California · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10357460

Particulate comprising a calcium-containing compound and a sugar alcohol

TAKEDA AS · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10357453

Methods of eye treatment using therapeutic compositions containing dipyridamole

O.D. Ocular Discovery Ltd. · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10357448

Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi

The Board of Regents of the University of Texas System · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2019224329

Incremental Dose Finding in Controlled-Release PTH Compounds

ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Thu Jul 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jul 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363248

Salts of heterocyclic modulators of HIF activity for treatment of disease

The Board of Regents of the University of Texas System · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363244

Compositions comprising metformin and a glucokinase activator

VTV THERAPEUTICS LLC · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10364252

Oxabicycloheptane prodrugs

Lixte Biotechnology, Inc. · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10364238

N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors

KalVista Pharmaceuticals Limited · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10364227

Therapeutic compounds

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363319

Glycoconjugates and methods for their use

The Board of Regents of the University of Texas System · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10364431

Compositions for treating muscular dystrophy

Sarepta Therapeutics, Inc. · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363246

Methods and compositions for treatment of epileptic disorders

OVID THERAPEUTICS INC. · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10364433

Modulation of AGPAT5 expression

The Regents of the University of California · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363241

Substituted imidazole derivatives and methods of use thereof

VTV THERAPEUTICS LLC · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363274

Renal cell populations and uses thereof

inRegen · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363311

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

The Board of Regents of the University of Texas System · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363312

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363294

Yeast-brachyury immunotherapeutic compositions

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10364258

Heteroaryl inhibitors of PDE4

Tetra Discovery Partners · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363293

Vaccine composition

TURNSTONE LIMITED PARTNERSHIP · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363286

Peptide inhibition of CCR3-mediated diseases or conditions

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363282

Analogs of C5a and methods of using same

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363273

Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

Iovance Biotherapeutics, Inc. · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363261

Enolase inhibitors and methods of treatment therewith

The Board of Regents of the University of Texas System · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363247

(S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer

Karyopharm Therapeutics Inc. · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363245

Methods for treating CNS lesions

The Board of Regents of the University of Texas System · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363237

Compositions and methods of inhibiting N-acylethanolamine-hydrolyzing acid amidase

The Regents of the University of California · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363289

Mutant OPAA enzyme with increased catalytic efficiency on GP

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363213

Immunogenic composition against Campylobacter jejuni

United States of America as represented by the Secretary of the Air Force · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363232

Compositions and methods for treating severe pain

Infirst Healthcare Limited · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10364275

Methods for treating inflammatory responses or diseases caused by inflammation using ApoA-I binding protein (APOA1BP)

The Regents of the University of California · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10364473

Fast diagnosis and personalized treatments for acne

The Regents of the University of California · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10364295

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

PRECISION BIOLOGICS, INC. · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10364233

Piperidine derivative and methods of use thereof

VTV THERAPEUTICS LLC · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363301

Stabilized influenza hemagglutinin stem region trimers and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363292

Vaccination with anti-tick antigens to control multiple tick species and disease transmission in white-tailed deer and other host animals

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363288

Insulin mimotopes and methods of using the same

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 3515433

DIE BLUT-HIRN-SCHRANKE PASSIERENDE DOPAMIN-B-HYDROXYLASE-INHIBITOREN

BIAL PORTELA & Cª S A [PT] · Granted Wed Jul 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jul 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10369106

Efficient aqueous encapsulation and controlled release of bioactive agents

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10368569

Natural sweetener

MONTERO GIDA SANAYI VE TICARET A.S. · Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10368543

Pest control using natural pest control agent blends

TYRATECH, INC. · Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10369098

Methods for localized drug delivery

Compass Therapeutics LLC · Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)